Skip to Content

NanoString Technologies Inc NSTG

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

NanoString Technologies Inc is a biotechnology company involved in translational research and molecular diagnostics. The product portfolio is based on a novel digital molecular barcoding technology. This technology, nCounter Analysis System, uses molecular barcodes and single-molecule imaging to distinguish and count hundreds of unique transcripts in a single reaction. Geographically, it derives maximum revenue from the Americas and also has a presence in Europe and Middle East, and the Asia Pacific. Other products and services include Analysis Solutions, GeoMx Digital Spatial Profiler, Gene Expression, Vantage 3D Assays, Sample Prep, and nCounter Consumables. The system is used for performing cancer research, biomarker validation and screening, and next-generation sequencing validation.

530 Fairview Avenue North
Seattle, WA, 98109
T +1 206 378-6266
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2020
Stock Type Distressed
Employees 551